Skip to main content

Advertisement

SpringerLink
Log in

Myeloablative unrelated cord blood transplantation for acute leukemia patients between 50 and 55 years of age: single institutional retrospective comparison with patients younger than 50 years of age

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Increasing recipient age is a well-known risk factor for graft-versus-host disease (GVHD) and treatment-related mortality (TRM) and has a negative impact on allogeneic hematopoietic stem cell transplantation. Since the incidence of severe GVHD after cord blood transplantation (CBT) is lower than that after transplants using bone marrow or mobilized peripheral blood grafts from adult cells, we should expect better outcomes from CBT in older patients. To evaluate the feasibility and efficacy of myeloablative unrelated CBT in patients aged between 50 and 55 years, we performed a retrospective comparison of 100 patients with acute leukemia who received cord blood grafts at our institution. Nineteen older patients (median age, 52; range, 50–55) and 81 younger patients (median, 36; range, 16–49) received a myeloablative conditioning regimen including 12 Gy of total body irradiation and chemotherapy. GVHD prophylaxis included cyclosporine with (n = 96) or without (n = 4) methotrexate. There were no significant differences in the incidences of grades II to IV acute GVHD, extensive-type chronic GVHD, TRM, and the probability of overall and disease-free survival between these groups. These results suggest that, in patients with acute leukemia, myeloablative CBT might be as safe and effective in patients aged between 50 and 55 years as in younger patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Klingemann HG, Storb R, Fefer A, Deeg HJ, Appelbaum FR, Buckner CD, Cheever MA, Greenberg PD, Stewart PS, Sullivan KM (1986) Bone marrow transplantation in patients aged 45 years and older. Blood 67:770–776

    PubMed  CAS  Google Scholar 

  2. Yanada M, Emi N, Naoe T, Sakamaki H, Iseki T, Hirabayashi N, Karasuno T, Chiba S, Atsuta Y, Hamajima N, Takahashi S, Kato S (2004) Allogeneic myeloablative transplantation for patients aged 50 years and over. Bone Marrow Transplant 34:29–35 doi:10.1038/sj.bmt.1704518

    Article  PubMed  CAS  Google Scholar 

  3. Farag SS, Elder PJ, Marcucci G, Penza S, Mrozek E, Molina A, Lin T, Avalos BR, Copelan E (2003) Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplantation in patients aged >or=50 years compared to younger adults with low-risk disease. Bone Marrow Transplant 31:87–93 doi:10.1038/sj.bmt.1703785

    Article  PubMed  CAS  Google Scholar 

  4. Du W, Dansey R, Abella EM, Baynes R, Peters WP, Klein J, Akhtar A, Cherednikova L, Karanes C (1998) Successful allogeneic bone marrow transplantation in selected patients over 50 years of age—a single institution’s experience. Bone Marrow Transplant 21:1043–1047 doi:10.1038/sj.bmt.1701210

    Article  PubMed  CAS  Google Scholar 

  5. Cahn JY, Labopin M, Schattenberg A, Reiffers J, Willemze R, Zittoun R, Bacigalupo A, Prentice G, Gluckman E, Hervé P, Gratwohl A, Gorin NC (1997) Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). Leukemia 11:416–419 doi:10.1038/sj.leu.2400573

    Article  PubMed  CAS  Google Scholar 

  6. Ringdén O, Horowitz MM, Gale RP, Biggs JC, Gajewski J, Rimm AA, Speck B, Veum-Stone JA, de Witte T, Bortin MM (1993) Outcome after allogeneic bone marrow transplant for leukemia in older adults. JAMA 270:57–60 doi:10.1001/jama.270.1.57

    Article  PubMed  Google Scholar 

  7. Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA, Petersdorf EW, Radich J, Sanders JE, Storb RF, Sullivan KM, Anasetti C (1998) Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 338:962–968 doi:10.1056/NEJM199804023381405

    Article  PubMed  CAS  Google Scholar 

  8. Nash RA, Pepe MS, Storb R, Longton G, Pettinger M, Anasetti C, Appelbaum FR, Bowden RA, Deeg HJ, Doney K (1992) Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis cyclosporine and methotrexate. Blood 80:1838–1845

    PubMed  CAS  Google Scholar 

  9. Carlens S, Ringdén O, Remberger M, Lönnqvist B, Hägglund H, Klaesson S, Mattsson J, Svahn BM, Winiarski J, Ljungman P, Aschan J (1998) Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant 22:755–761 doi:10.1038/sj.bmt.1701423

    Article  PubMed  CAS  Google Scholar 

  10. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM (2004) Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351:2265–2275 doi:10.1056/NEJMoa041276

    Article  PubMed  CAS  Google Scholar 

  11. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, Jacobsen N, Ruutu T, de Lima M, Finke J, Frassoni F, Gluckman E, Acute Leukemia Working Party of European Blood and Marrow Transplant Group Eurocord-Netcord Registry (2004) Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351:2276–2285 doi:10.1056/NEJMoa041469

    Article  PubMed  CAS  Google Scholar 

  12. Takahashi S, Iseki T, Ooi J, Tomonari A, Takasugi K, Shimohakamada Y, Yamada T, Uchimaru K, Tojo A, Shirafuji N, Kodo H, Tani K, Takahashi T, Yamaguchi T, Asano S (2004) Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 104:3813–3820 doi:10.1182/blood-2004-03-1001

    Article  PubMed  CAS  Google Scholar 

  13. Takahashi S, Ooi J, Tomonari A, Konuma T, Tsukada N, Oiwa-Monna M, Fukuno K, Uchiyama M, Takasugi K, Iseki T, Tojo A, Yamaguchi T, Asano S (2007) Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 109:1322–1330 doi:10.1182/blood-2006-04-020172

    Article  PubMed  CAS  Google Scholar 

  14. Ooi J, Iseki T, Takahashi S, Tomonari A, Takasugi K, Uchiyama M, Konuma T, Futami M, Nomura A, Nakayama S, Soda Y, Ohno N, Nagamura F, Uchimaru K, Tojo A, Tani K, Asano S (2004) Unrelated cord blood transplantation after myeloablative conditioning in patients over the age of 45 years. Br J Haematol 126:711–714 doi:10.1111/j.1365-2141.2004.05130.x

    Article  PubMed  Google Scholar 

  15. Konuma T, Ooi J, Takahashi S, Tomonari A, Uchiyama M, Fukuno K, Tsukada N, Iseki T, Tojo A, Asano S (2006) Unrelated cord blood transplantation after myeloablative conditioning in patients with acute leukemia aged between 50 and 55 years. Bone Marrow Transplant 37:803–804 doi:10.1038/sj.bmt.1705334

    Article  PubMed  CAS  Google Scholar 

  16. Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kobayashi T, Sato A, Takasugi K, Iseki T, Tojo A, Asano S (2007) Bacterial bloodstream infection in neutropenic adult patients after myeloablative cord blood transplantation: experience of a single institution in Japan. Int J Hematol 85:238–241 doi:10.1532/IJH97.06179

    Article  PubMed  Google Scholar 

  17. Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kobayashi T, Takasugi K, Iseki T, Tojo A, Asano S (2008) Preemptive therapy with ganciclovir 5 mg/kg once daily for cytomegalovirus infection after unrelated cord blood transplantation. Bone Marrow Transplant 41:371–376 doi:10.1038/sj.bmt.1705910

    Article  PubMed  CAS  Google Scholar 

  18. Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kobayashi T, Sato A, Iseki T, Yamaguchi T, Tojo A, Asano S (2007) Impact of ABO incompatibility on engraftment and transfusion requirement after unrelated cord blood transplantation: a single institute experience in Japan. Bone Marrow Transplant 40:523–528 doi:10.1038/sj.bmt.1705765

    Article  PubMed  CAS  Google Scholar 

  19. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18:295–304 doi:10.1097/00007890-197410000-00001

    Article  PubMed  CAS  Google Scholar 

  20. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi MS, Storb R, Thomas ED (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69:204–217 doi:10.1016/0002-9343(80)90380-0

    Article  PubMed  CAS  Google Scholar 

  21. Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18:695–706 doi:10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O

    Article  PubMed  CAS  Google Scholar 

  22. Cox DR (1972) Regression models and life tables. J R Stat Soc B 34:187–220

    Google Scholar 

  23. Alyea EP, Kim HT, Ho V, Cutler C, Gribben J, DeAngelo DJ, Lee SJ, Windawi S, Ritz J, Stone RM, Antin JH, Soiffer RJ (2005) Comparative outcome of nonmyeloablative and myeloablative cell transplantation for patients older than 50 years of age. Blood 105:1810–1814 doi:10.1182/blood-2004-05-1947

    Article  PubMed  CAS  Google Scholar 

  24. Aoudjhane M, Labopin M, Gorin NC, Shimoni A, Ruutu T, Kolb HJ, Frassoni F, Boiron JM, Yin JL, Finke J, Shouten H, Blaise D, Falda M, Fauser AA, Esteve J, Polge E, Slavin S, Niederwieser D, Nagler A, Rocha V, Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT) (2005) Comparative outcome of reduced intensity and myeloablative conditining regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group of Blood and Marrow Transplantation (EBMT). Leukemia 19:2304–2312 doi:10.1038/sj.leu.2403967

    Article  PubMed  CAS  Google Scholar 

  25. Shimoni A, Hardan I, Shem-Tov N, Yeshurun M, Yerushalmi R, Avigdor A, Ben-Bassat I, Nagler A (2006) Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity. Leukemia 20:322–328 doi:10.1038/sj.leu.2404037

    Article  PubMed  CAS  Google Scholar 

  26. Kojima R, Kami M, Kanda Y, Kusumi E, Kishi Y, Tanaka Y, Yoshioka S, Morishima S, Fujisawa S, Mori SI, Kasai M, Hatanaka K, Tajima K, Kasai M, Mitani K, Ichinohe T, Hirai H, Taniguchi S, Sakamaki H, Harada M, Takaue Y (2005) Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 years. Bone Marrow Transplant 36:667–674 doi:10.1038/sj.bmt.1705122

    Article  PubMed  CAS  Google Scholar 

  27. Uchida N, Wake A, Takagi S, Yamamoto H, Kato D, Matsuhashi Y, Matsumura T, Seo S, Matsuno N, Masuoka K, Kusumi E, Yuji K, Miyakoshi S, Matsuzaki M, Yoneyama A, Taniguchi S (2008) Umbilical cord blood transplantation after reduced-intensity conditioning for elderly patients with hematologic diseases. Biol Blood Marrow Transplant 14:583–590 doi:10.1016/j.bbmt.2008.03.003

    Article  PubMed  Google Scholar 

  28. Majhail NS, Brunstein CG, Tomblyn M, Thomas AJ, Miller JS, Arora M, Kaufman DS, Burns LJ, Slungaard A, McGlave PB, Wagner JE, Weisdorf DJ (2008) Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biol Blood Marrow Transplant 14:282–289 doi:10.1016/j.bbmt.2007.12.488

    Article  PubMed  CAS  Google Scholar 

  29. Brunstein CG, Barker JN, Weisdorf DJ, DeFor TE, Miller JS, Blazar BR, McGlave PB, Wagner JE (2007) Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 110:3064–3070 doi:10.1182/blood-2007-04-067215

    Article  PubMed  CAS  Google Scholar 

  30. Chao NJ, Koh LP, Long GD, Gasparetto C, Horwitz M, Morris A, Lassiter M, Sullivan KM, Rizzieri DA (2004) Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens. Biol Blood Marrow Transplant 10:569–575 doi:10.1016/j.bbmt.2004.05.001

    Article  PubMed  Google Scholar 

  31. Miyakoshi S, Yuji K, Kami M, Kusumi E, Kishi Y, Kobayashi K, Murashige N, Hamaki T, Kim SW, Ueyama J, Mori S, Morinaga S, Muto Y, Masuo S, Kanemaru M, Hayashi T, Takaue Y, Taniguchi S (2004) Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clin Cancer Res 10:3586–3592 doi:10.1158/1078-0432.CCR-03-0754

    Article  PubMed  Google Scholar 

  32. Narimatsu H, Watanabe M, Kohno A, Sugimoto K, Kuwatsuka Y, Uchida T, Murata M, Miyamura K, Morishita Y, Nagoya Blood and Marrow Transplantation Group (NBMTG) (2008) High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan. Bone Marrow Transplant 41:753–756 doi:10.1038/sj.bmt.1705978

    Article  PubMed  CAS  Google Scholar 

  33. Bär BM, De Witte T, Schattenberg A, Boezeman J, Hoogenhout J (1990) Favourable outcome of patients older than 40 years of age after transplantation with marrow grafts depleted of lymphocytes by counterflow centrifugation. Br J Haematol 74:53–60 doi:10.1111/j.1365-2141.1990.tb02537.x

    Article  PubMed  Google Scholar 

  34. Novitzky N, Thomas V, Hale G, Waldmann H (2005) Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted grafts. Bone Marrow Transplant 36:675–682 doi:10.1038/sj.bmt.1705119

    Article  PubMed  CAS  Google Scholar 

  35. Jakubowski AA, Small TN, Young JW, Kernan NA, Castro-Malaspina H, Hsu KC, Perales MA, Collins N, Cisek C, Chiu M, van den Brink MR, O’Reilly RJ, Papadopoulos EB (2007) T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. Blood 110:4552–4559 doi:10.1182/blood-2007-06-093880

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors are indebted to the medical and nursing staff for taking care of the patients in this study. We also thank the Kobayashi Foundation for financial support and Maki Monna-Oiwa for her secretarial assistance.

Author information

Authors and Affiliations

  1. Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan

    Takaaki Konuma, Satoshi Takahashi, Jun Ooi, Akira Tomonari, Nobuhiro Tsukada, Seiko Kato, Aki Sato, Fumihiko Monma, Senji Kasahara, Kaoru Uchimaru, Tohru Iseki, Arinobu Tojo & Shigetaka Asano

  2. Department of Transfusion Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

    Tokiko Nagamura-Inoue

  3. Department of Clinical Trial Data Management, The University of Tokyo, Tokyo, Japan

    Takuhiro Yamaguchi

Authors
  1. Takaaki Konuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Satoshi Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jun Ooi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Akira Tomonari
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nobuhiro Tsukada
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Seiko Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Aki Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Fumihiko Monma
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Senji Kasahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Tokiko Nagamura-Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Kaoru Uchimaru
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Tohru Iseki
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Arinobu Tojo
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Takuhiro Yamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Shigetaka Asano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Satoshi Takahashi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Konuma, T., Takahashi, S., Ooi, J. et al. Myeloablative unrelated cord blood transplantation for acute leukemia patients between 50 and 55 years of age: single institutional retrospective comparison with patients younger than 50 years of age. Ann Hematol 88, 581–588 (2009). https://doi.org/10.1007/s00277-008-0641-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-008-0641-2

Keywords

Search

Navigation